Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Balding men had lower bone density, while balding women had higher hip bone density.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Autologous progenitor cell transplantation can effectively improve hair growth and quality with minimal side effects.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

A single injection of PTH–CBD can increase bone density for up to a year.

Estradiol gel can cause hair loss in dogs.

Hibiscus flower extract slowed down hair growth in rats.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

Differences in enzyme activity and androgen receptors in hair follicles may explain why hair loss appears differently in men and women.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Women with androgenetic alopecia have fewer terminal hairs, phenol in nail surgery is safe, and a new hair transplant method is faster and less damaging.

Hair restoration techniques and new cell sources improve hair loss treatments.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

PCOS can cause excess hair growth, oily skin, hair loss, acne, and dark skin patches.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Long-term use of minoxidil may cause hair follicles to transform into noticeable terminal hairs, leading to trichostasis spinulosa.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Follicular red dots may be a normal feature seen in people with less skin pigmentation, not necessarily indicating a scalp disorder.

LLLT is a safe, promising hair loss treatment, but more research needed.

Minoxidil base is preferred for hair loss treatment, but minoxidil sulfate may be an alternative for unresponsive patients.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.